Africa CDC Centres for Disease Control and Prevention
7
African Union
7
World Health Organisation (WHO)
5
World Health Organization WHO, Regional Office of Europe
4
Clinical Care Options
3
European Centre for Disease Prevention and Control
3
Mauder, S.
3
WHO
3
World Health Organization (WHO)
3
and P. Reijer
2
Dept. of Health, Republic of South Africa
2
et al.
2
Internews
2
Kamps, B.S.
2
MEDBOX
2
Mission Rabies
2
Pan American Health Organisation PAHO
2
Sallam, M.
2
UN Children's Fund UNICEF
2
World Health Organization WHO, et al.
2
A. García-Prado, J.P. Sarmiento, et al.
1
Action against AIDS
1
African Union, African CDC, World Health Organisation
1
AIDSinfo
1
Alliance for Health Policy and Systems Research (AHPSR) and World Health Organization
1
Ana Maria Henao-Restrepo, Ira M Longini, Matthias Egger, et al.
1
and J. Rüppel
1
Argote P., Barhan E., Zukerman Daly S. et al.
1
Arrieta, A.
1
Assessment Capacities Project
1
Assessment Capacities Project ACAPS
1
Australian Commission on Safety and Quality in Health Care (ACSQHC)
1
B.S. Kamps
1
Barben et al.
1
Barmer
1
Bill & Melinda Gates Foundation
1
Bishop, G.
1
British Society for Immunology
1
Brown C.M., Slavinski S., Ettestad P. et al
1
Buliva E., Elnossery S., Okwarah P. et al.
1
C. Hoffmann, et al.
1
Camp, R. and C. Hoffmann
1
Caroline Favas
1
Center for Operational Analysis and Research COAR
1
Cerda A. A., Garcia L. Y.
1
Chatanga, Peter
1
Child Health Division
1
Christina Brandes-Barbier, Véronique Millot, Tomas Allen et al
1
CIDRAP
1
Cilliers, J.
1
Coalition for Epidemic Preparedness Innovations (CEPI)
1
Corfmat, J.
1
David H. Peters, Nhan T. Tran, Taghreed Adam
1
Department: Agriculture, Foresty and Fisheries - Republic of South Africa
1
Dermot Maher
1
Deutschen Gesellschaft für Pädiatrische Infektiologie (DGPI) e.V.
1
Die Johanniter
1
Durrheim, D.
1
EQUINET
1
EuroHealth Observer
1
European Asylum Support Office
1
European Centre for Disease Prevention and Control ECDC
1
European Observatory on Health Systems and Policies Eurostation
1
European specialist nurse organisation (ESN)
1
Extended Programme on Immunisation NDoH
1
Feiterna- Sperling, C., F. Brinkmann, C. Adamzik, et al.
1
Fédération Internationale des Societés de la Croix-Rouge et du Croissant Rouge
1
Florida International University
1
Food and Drug Administration (FDA)
1
G. K. Siberry
1
German Red Cross
1
Gibson, A.
1
Government of Kenya
1
Government of Malawi
1
Gromek K., Hung M., Montero N. et al
1
Health Cluster, WHO
1
Heliyon
1
Hoffmann, C.
1
Human Rights Watch
1
Imperial College COVID-19 Response Team
1
Institute for Security Studies ISS
1
International Dairy Federation
1
International Livestock Research Institute ILRI
1
International Pharmaceutical Federation FIP
1
James W. Macharia
1
K. Lancaster
1
Keymanthri Moodley, Kate Hardie, Michael J Selgelid, et al.
1
Kim, A.
1
Kloeck, P. et al.
1
Kompetenznetz Pulic Health Covid-19
1
LaRocque, R.
1
Lawrence Mayega, Michel M. Dione, Brian Kawuma, et al.
1
London School of Hygiene and Tropical Medicine
1
Lungenliga Schweiz, Bundesamt für Gesundheit
1
M. J. Abzug
1
María Eugenia Grillet, Fabiola Del Ventura
1
Masumbuko ClaudeK, Underschultz J,Hawkes MT
1
Medical Mission Institute
1
Ministry of Health and Social Welfare, Government of India
1
Ministry of Health and Social Welfare, Government of Lesotho
1
Ministry of Health Kenya
1
Ministry of Health Rwanda, Biomedical Center Institute of HIV
1
Ministry of Health& Family Welfare, Goverment of India
1
Ministry of Health, Ghana, World Health Organizaiotn (WHO) and Ghana Health Service
1
Ministry of Health, Kenya
1
Ministry of Health, Kingdom of Lesotho
1
Ministry of Health, Malawi
1
Mugomeri, Eltony
1
National Association of State Public Health Veterinarians Compendium of Animal Rabies Prevention and Control Committee
1
National HIV and AIDS Secretariat
1
National Polio Emergency Operations Centre (EOC), Islamabad, Pakistan
1
National Primary Health Care Development Agency, Abuja, Nigeria
1
nature communications
1
Nature Video
1
NCTSN
1
NDoH South Africa
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
NFPA-UNICEF Joint Programme on Female Genital Mutilation/ Cutting (FGM/C)
1
Nigeria Center for Disease Control, Federal Ministry of Health, Abuja
1
NPJ
1
Nuffield Council on Bioethics
1
Office for the Coordination of Humanitarian Affairs OCHA
1
Open WHO
1
Organisation Mondiale de la Santé, Bureau régional de l'OMS pour l'Afrique
1
Organização Mundial da Saúde. Escritório Regional para a África
1
Patrick R. Kenya, Prince-Albert Roberts, Joseph Kobba, et al.
1
PMC (US National Library of Medicine National Institutes of Health)
1
Pontifical Academy for Life
1
R Loewenson
1
R Sari Kovats et al.
1
R. Velayudhan
1
Raditladi, Tirelo et al.
1
REACH
1
Rhodes, T.
1
Robert-Koch-Institut RKI
1
Rüppel, T.
1
RüppelT.
1
S. Galwankar
1
S. Lees et al.
1
S. Nachman et al.
1
S.B. Calderwood and A.Bloom
1
S.R. Lewin and R. Sherer
1
Sachs, J., Karim, S., Aknin, L. et al.
1
Sage Working Group on Vaccine Hesitancy
1
Schmidt-Sane M.
1
Social Science in Humanitarian Action
1
Social Science in Humanitarian Action Platform
1
SSHAP
1
T. Jaenisch, K.D. Rosenberger, C. Brito, et al
1
TDR Program
1
The Johns Hopkins Center for Humanitarian Healt
1
The Lancet Commissions
1
The National Child Traumatic Stress Network
1
The ROTA Council
1
The Swedish Veterinary Association SVS
1
Tribuna del Investigador
1
Umited Nations Popuilation Fund UNFPA
1
UN High Commissioner for Refugees
1
UNICEF
1
UNICEF and UNFPA
1
UpToDate
1
USAID
1
V. Parikh
1
V. Tucci
1
Vatican COVID-19 Commission
1
Wellcome Trust
1
Wesern Cape Government, South Africa
1
World Council of Churches WCC
1
World Health Organization (WHO), Regional Office for South-East Asia
1
World Health Organization ( WHO), Regional Office for Africa
1
World Health Organization - Regional Office for South-East Asia
1
World Health Organization WHO, Regional Office for Africa
1
World Health Organization WHO, Regional Office of Africa
1
World Health Organization, Ethopian country office
1
World Health Organization, Regional Office South-East Asia
1
Yale, G.
1
Publication Years
2020-2024
154
2010-2019
25
2000-2009
3
Category
COVID-19
24
Vaccine-preventable Diseases
15
Policies
12
Studies & Reports
12
Guidelines
8
Disease Prevention & Control
8
Immunization
5
x MEDBOX Issue Brief & Annual Reports x
3
Information, Education and Communication (IEC)
3
Humanitarian Crisis
3
Vector Control
2
Cervical Cancer
2
Diarrhoeal Disease/Cholera
2
Women & Child Health
2
Community Health
2
Statistics
2
General Guidelines
2
NTDs & Others
2
Communicable Diseases
1
Rabies
1
Public Health
1
Disaster Preparedness
1
Online Courses & Platforms
1
Cancer
1
Community Health
1
Infection Control & Prevention (IPC)
1
Countries
1
Health System Strengthening
1
Child protection
1
Yellow Fever
1
Drugs & Medical Equipment
1
Capacity Building
1
Other
1
Diarrhoea
1
Needs Assessment
1
Female Genital Mutilation
1
Health Systems
1
Dengue
1
Leishmaniasis
1
Reproductive Health
1
Global Health
1
Toolboxes
Country specific documents
11
Communication Material
10
Vaccine Hesitancy & Myths
10
Global Impact: Socio-economic, health services, TB & HIV
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are... disappearing, but other serogroups (e.g. NmW, NmX and NmC) still cause epidemics, albeit at a lower frequency and of a smaller size. Due to these changes, WHO organized the review of the evidence to provide recommendations for epidemic control, related to operational thresholds for investigation and response to outbreaks, the use of rapid diagnostic tests, antibiotic regimens in epidemics, and prophylaxis for household contacts of casesmore
In 1998 the Swedish Veterinary Association decided to adopt a general policy for the use of antibiotics in animals. Since then specifi c policies for the use of antibiotics in dogs and cats have been adopted and in 2011 Guidelines for the use of Antibiotics in Production animals – Cattle and Pigs,... were accepted. By decision of the board of the Swedish Veterinary Society (SVS) these guidelines have been updated. Th e over-arching goal of SVS is to achieve a low and controlled use of antibiotics in Swedish animal production so that the fi rst-hand choices of treatment remain effi cient and that the spread of antimicrobial resistance – among animals and herds as well as in the food chain – is kept at a minimum. Keeping antimicrobial resistance in animals low is important also for human health, since we are all part of the same ecosystem. Th e authors of these guidelines hope that they may be useful for veteri-narians in clinical practice when deciding on treatments for common diseases and ailments caused by bacteria. Sometimes the decision may even be to refrain from use of antibiotics and chose other ways of improving herd health.more
Coronavirus disease (COVID-19) science conversation
In this video and audio series WHO experts explain the science related to COVID-19. This series is available every week on WHO's YouTube, Instagram, Facebook, Twitter, and LinkedIn channels and on all major podcasts platforms.
Download all epis...ode transcripts in Arabic, Chinese, English, French, Portuguese, Russian, Spanish, Hindi, Maithili, Nepalimore
As the world waits for a potential COVID-19 vaccine, we delve into how vaccines actually work. What are the different types of vaccine? How do they trigger and train the immune system, and what is the role of herd immunity?
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...nd Melinda Gates Foundation and the Mastercard Foundation. These partners have helped to shape and drive the continent’s strategic response to the COVID-19 pandemic and have offered support to ensure the continent receives a fair and equitable share of the COVID-19 vaccine without delay.
We look forward to continuing and deepening our partnership for the benefit of the public health of Africa.more
As new variants emerge people are wondering if they should wait until a more efficacious vaccine is available or if they should go ahead and get vaccinated now? Answering your questions on COVID-19 vaccines and variants in this episode of Science in 5 is WHO's Dr Soumya Swaminathan.
March 9, 2021
Here you can find a collection of useful manuals, videos, infographics and resource platforms.
The category "Vaccine hesitancy & myths" will be updated regularly with new documents, videos and information material. Please check this category within the COVID-19
https://medbox.org/fi...lter/602505261716D/toolbox/vaccination-strategy#GOmore
The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK.
This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will b...e updated as it becomes available.more
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
Many African countries were amongst the most rapid to respond to the emerging threat of COVID-19, implementing large-scale interventions at very early stages of their epidemic. As demonstrated in this document using very simple models, this rapid mobilization and timeliness of implementing control m...easures is likely to be an important determinant of their success. Indeed, as these measures were relaxed, subsequent waves of disease have been observed in many countries including South Africa, Kenya, Tunisia, Morocco, Sudan and the Democratic Republic of Congo (DRC) where such waves have severely impacted the health system by straining the supply of oxygen and ICU beds and inflicting a heavy toll on healthcare workers, often necessitating the re-imposition of control measures.more
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv...e features of mass vaccination campaigns—the vaccine’s producer, efficacy, endorser, distributor, and current population uptake rate—shifted willingness to take a COVID-19 vaccine. We find that citizens preferred Western-produced vaccines, but were highly influenced by factual information about vaccine efficacy. Vaccine hesitant individuals were more responsive to vaccine messengers with medical expertise than political, religious, or media elite endorsements. Citizen trust in foreign governments, domestic leaders, and state institutions moderated the effects of the campaign features on vaccine acceptance. These findings can help inform the design of unfolding mass inoculation campaigns.more
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important
to identify sources of variation so that policies can be tailored to different population groups. ...In this paper, we analyze the results from a survey designed and implemented in order to identify early adopters and
laggers in six big cities of Latin America. We find that trust in government and science, accurate knowledge about the value of vaccination and vaccine effects, perceived risk of getting sick, and being a student
increase the odds to get vaccinated. We also identify potential laggers as women and populations between 20 and 35 years old who are not students. We discuss specific strategies to promote vaccination among
these populations groups as well as more general strategies designed to gain trust. These findings are specific to the context of Latin America insofar as the underlying factors associated with the choice to be
vaccinated vary significantly by location and in relation to individual-level factors.more
All health workers deployed to measles outbreaks must complete the measles and rubella (MR) training to implement quality interventions and work safely and effectively in the field. This course provides the essential preparedness, detection, investigation, response, and recovery skills required to c...ontain the measles outbreak.more
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...velopment of next-generation vaccines against COVID-19 variants and we are planning studies to answer critical scientific questions related to the durability of immunity, effectiveness of mixed-vaccine regimens, and vaccine effectiveness in vulnerable populations such as pregnant women. We are also bringing forward our plans to develop vaccines that could protect against multiple COVID-19 variants and other coronavirus speciemore